A retinoic acid receptor β agonist (CD2019) overcomes inhibition of axonal outgrowth via phosphoinositide 3-kinase signalling in the injured adult spinal cord

TY - JOUR

T1 - A retinoic acid receptor β agonist (CD2019) overcomes inhibition of axonal outgrowth via phosphoinositide 3-kinase signalling in the injured adult spinal cord

AU - Agudo, Marta

AU - Yip, Ping

AU - Davies, Meirion

AU - Bradbury, Elizabeth

AU - Doherty, Patrick

AU - McMahon, Stephen

AU - Maden, Malcolm

AU - Corcoran, Jonathan P. T.

PY - 2010/1

Y1 - 2010/1

N2 - After spinal cord injury in the adult mammal, axons do not normally regrow and this commonly leads to paralysis. Retinoic acid (RA) can stimulate neurite outgrowth in vitro of both the embryonic central and peripheral nervous system. via activation of the retinoic acid receptor (RAR) beta 2 We show here that regions of the adult CNS. including the cerebellum and cerebral cortex, express RAR beta 2. We show that when cerebellar neurons are grown in the presence of myelin-associated glycoprotein (MAC) which inhibits neurite outgrowth, RAR beta can be activated in a dose dependent manner by a RAR beta agonist (CD2019) and neurite outgrowth can occur via phosphoinositide 3-kinase (PI3K) signalling. In a model of spinal cord injury CD2019 also acts through PI3K signalling to induce axonal outgrowth of descending corticospinal fibres and promote functional recovery Our data suggest that RAR beta agonists may be of therapeutic potential for human spinal cord injuries.

AB - After spinal cord injury in the adult mammal, axons do not normally regrow and this commonly leads to paralysis. Retinoic acid (RA) can stimulate neurite outgrowth in vitro of both the embryonic central and peripheral nervous system. via activation of the retinoic acid receptor (RAR) beta 2 We show here that regions of the adult CNS. including the cerebellum and cerebral cortex, express RAR beta 2. We show that when cerebellar neurons are grown in the presence of myelin-associated glycoprotein (MAC) which inhibits neurite outgrowth, RAR beta can be activated in a dose dependent manner by a RAR beta agonist (CD2019) and neurite outgrowth can occur via phosphoinositide 3-kinase (PI3K) signalling. In a model of spinal cord injury CD2019 also acts through PI3K signalling to induce axonal outgrowth of descending corticospinal fibres and promote functional recovery Our data suggest that RAR beta agonists may be of therapeutic potential for human spinal cord injuries.

U2 - 10.1016/j.nbd.2009.09.018

DO - 10.1016/j.nbd.2009.09.018

M3 - Article

VL - 37

SP - 147

EP - 155

JO - Neurobiology of Disease

JF - Neurobiology of Disease

IS - 1

ER -